[EYES] Second Sight Medical Products, Inc.

Overview

Type of security: Stock

Sector:

Industry:

Market Capitalization: 145.96 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 2.13 Change: 0.08 (3.9%)
Ext. hours: Change: 0 (0%)

chart EYES

Refresh chart

Strongest Trends Summary For EYES

EYES is in the long-term down -53% below S&P in 2 years and down -97% below S&P in 7 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Second Sight Medical Products, Inc., a medical device company, develops, manufactures, and markets implantable prosthetic devices to restore functional vision to blind patients. The company provides Argus II system, an implantable neurostimulation device for the treatment of outer retinal degenerations, such as retinitis pigmentosa. It has operations in North America, Europe, and the Middle East. The company was formerly known as Second Sight LLC. Second Sight Medical Products, Inc. was founded in 1998 and is headquartered in Sylmar, California.

Fundamental Ratios
Shares Outstanding36.04 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 178.23% Sales Growth - Q/Q11.84% P/E
P/E To EPS Growth P/S32.87 P/BV4.79 Price/Cash Per Share4.91
Price/Free Cash Flow-8.27 ROA-85.46% ROE-110.7% ROI
Current Ratio4.27 Quick Ratio3.56 Long Term Debt/Equity Debt Ratio0.3
Gross Margin7.05% Operating Margin-489.6% Net Profit Margin-759.41% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities290 K Cash From Investing Activities4.83 M Cash From Operating Activities-5.03 M Gross Profit400 K
Net Profit-4.96 M Operating Profit-4.96 M Total Assets39.46 M Total Current Assets38.4 M
Total Current Liabilities9 M Total Debt Total Liabilities9 M Total Revenue1.7 M
Technical Data
High 52 week1.97 Low 52 week0.65 Last close0.84 Last change5.66%
RSI39.05 Average true range0.05 Beta0.68 Volume438.22 K
Simple moving average 20 days0.2% Simple moving average 50 days7.19% Simple moving average 200 days-8.75%
Performance Data
Performance Week4.87% Performance Month8.67% Performance Quart-12.04% Performance Half20.69%
Performance Year-44.74% Performance Year-to-date-5.19% Volatility daily3.12% Volatility weekly6.97%
Volatility monthly14.28% Volatility yearly49.46% Relative Volume704.36% Average Volume218.28 K
New High New Low

News

2019-11-14 17:35:10 | Second Sight Medical Products EYES Reports Q3 Loss, Lags Revenue Estimates

2019-11-14 16:05:00 | Second Sight Reports Third Quarter 2019 Financial Results

2019-11-07 10:30:03 | Will Second Sight Medical Products EYES Report Negative Earnings Next Week? What You Should Know

2019-11-07 06:51:54 | What Kind Of Investor Owns Most Of Second Sight Medical Products, Inc. NASDAQ:EYES?

2019-11-05 16:30:00 | Second Sight to Discuss Third Quarter 2019 Financial Results on November 14, 2019 Conference Call

2019-10-30 10:33:02 | Second Sight Medical Products EYES May Report Negative Earnings: Know the Trend Ahead of Q3 Release

2019-10-02 08:30:13 | Imagine Owning Second Sight Medical Products NASDAQ:EYES And Trying To Stomach The 77% Share Price Drop

2019-10-01 08:00:00 | Second Sight Announces $2.4 Million, Four-Year Grant from National Institutes of Health to Develop Spatial Localization and Mapping Technology

2019-09-02 09:54:31 | Edited Transcript of EYES earnings conference call or presentation 6-Aug-19 8:30pm GMT

2019-08-28 08:00:00 | Second Sight to Present at September Investor Conferences

2019-08-27 10:33:28 | How Many Second Sight Medical Products, Inc. NASDAQ:EYES Shares Did Insiders Buy, In The Last Year?

2019-08-06 19:05:11 | Second Sight Medical Products EYES Reports Q2 Loss, Tops Revenue Estimates

2019-08-06 16:05:00 |  Second Sight Reports Second Quarter 2019 Financial Results

2019-07-30 16:30:00 | Second Sight to Discuss Second Quarter 2019 Financial Results on August 6, 2019 Conference Call

2019-07-30 10:38:02 | Second Sight Medical Products EYES May Report Negative Earnings: Know the Trend Ahead of Q2 Release

2019-07-11 10:53:02 | How Much is Second Sight Medical Products, Inc.'s NASDAQ:EYES CEO Getting Paid?

2019-06-25 16:05:00 | Researchers Present Latest Positive Results of Second Sight’s Orion Visual Cortical Prosthesis Feasibility Study

2019-05-16 17:00:00 | Second Sight to Present at 20th Annual B. Riley FBR Investor Conference

2019-05-15 22:39:23 | Edited Transcript of EYES earnings conference call or presentation 15-May-19 8:30pm GMT

2019-05-15 17:25:09 | Second Sight Medical Products EYES Reports Q1 Loss, Misses Revenue Estimates

2019-05-15 16:15:40 | Second Sight Medical Products: 1Q Earnings Snapshot

2019-05-15 16:05:00 | Second Sight Reports First Quarter 2019 Financial Results

2019-05-15 16:01:00 | Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System

2019-05-08 08:00:00 | Second Sight to Discuss First Quarter 2019 Financial Results on May 15, 2019 Conference Call

2019-05-02 10:32:02 | Second Sight Medical Products EYES May Report Negative Earnings: Know the Trend Ahead of Q1 Release

2019-04-17 09:13:22 | Imagine Owning Second Sight Medical Products NASDAQ:EYES And Trying To Stomach The 80% Share Price Drop

2019-04-11 08:00:00 | Second Sight Medical Products, Inc. Presents Positive Interim Results at the Fifth Annual BRAIN Initiative® Investigators Meeting

2019-04-04 10:49:02 | Zacks.com featured highlights include: VALE, Second Sight, Carbonite, Arconic and vTv

2019-04-03 07:57:11 | Get Over Bargain Hunting: Tap 5 Stocks With Rising P/E

2019-03-19 12:26:04 | Zacks.com featured highlights include: Catabasis, Ligand, Key, Carbonite and Second Sight

2019-03-18 09:02:01 | Rising P/E an Overlooked Criterion: 5 Top Stocks

2019-03-13 23:40:11 | Edited Transcript of EYES earnings conference call or presentation 13-Mar-19 8:30pm GMT

2019-03-13 16:34:13 | Second Sight Medical Products: 4Q Earnings Snapshot

2019-03-13 16:05:00 | Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results

2019-03-12 08:46:33 | Have Insiders Been Buying Second Sight Medical Products, Inc. NASDAQ:EYES Shares This Year?

2019-03-06 08:00:00 | Second Sight to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019 Conference Call

2019-02-21 18:06:00 | Second Sight Medical Products, Inc. Announces Completion of Rights Offering

2019-01-22 07:35:00 | Recent Analysis Shows Abercrombie & Fitch, DaVita, W.W. Grainger, Ingredion, FirstEnergy, and Second Sight Medical Products Market Influences — Renewed Outlook, Key Drivers of Growth

2019-01-07 08:05:00 | Second Sight Medical Products, Inc. Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants EYESW Expiration Date

2019-01-07 08:00:00 | Second Sight Reports Fourth Quarter 2018 Business Update

2018-12-20 08:00:00 | Second Sight to Present at Digital Medicine and Medtech Showcase 2019

2018-12-14 08:00:00 | Second Sight Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors

2018-12-04 06:18:11 | Second Sight Medical Products Sees Hammer Chart Pattern: Time to Buy?

2018-11-27 16:30:00 | Second Sight to Present at the 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th

2018-11-12 08:15:00 | Research Report Identifies Prudential Financial, Second Sight Medical Products, Acushnet, Repligen, Scorpio Tankers, and Aethlon Medical with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-11-08 05:21:09 | Edited Transcript of EYES earnings conference call or presentation 7-Nov-18 9:30pm GMT

2018-11-07 19:10:12 | Second Sight Medical Products EYES Reports Q3 Loss, Lags Revenue Estimates

2018-11-07 18:06:22 | Second Sight Medical Products: 3Q Earnings Snapshot

2018-11-07 16:01:00 | Second Sight Reports Third Quarter 2018 Financial Results

2018-11-06 16:01:00 | Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System